House · Republican · MT-2 · in the House since 2021 · Latest annual report · rosendale.house.gov
From the annual report filed Jan 30, 2025 · Report
No trades reported.
Transactions an annual report lists for the year it covers, apart from trade reports. Not counted in the trades above.
| Traded | Company | Trade | Amount | Investor | Report |
|---|---|---|---|---|---|
| Dec 6, 2024 | US Treasury ser note 2029 | Buy · Government bond | $100K – $250K | Self | 2025 Annual Report filed Jan 30, 2025 |
| Jul 24, 2024 | US Treasury ser note 2026 | Buy · Government bond | $100K – $250K | Self | 2025 Annual Report filed Jan 30, 2025 |
| Jun 5, 2024 | US Treasury ser note 2026 | Sale · Government bond | $100K – $250K | Self | 2025 Annual Report filed Jan 30, 2025 |
| May 3, 2024 | US Treasury ser note 2028 | Buy · Government bond | $100K – $250K | Self | 2025 Annual Report filed Jan 30, 2025 |
| May 3, 2024 | Thermo Fisher Scientific Inc | Buy · Stock | $15K – $50K | Self | 2025 Annual Report filed Jan 30, 2025 |
From Matthew M. Rosendale, Sr.'s filings with the House Clerk. Members report trades and holdings in ranges, not exact amounts. Holdings are the assets in the latest annual report; trades since then are not netted into them.
Loading...